Yin Wan

Statistics

Publications

Citations

H-Index

Active since

2024

Affiliations

Yin Wan is an author at Mayo Clinic in Arizona specializing in anaplastic lymphoma kinase inhibitors, tyrosine kinase inhibitor therapy, and anaplastic lymphoma kinase inhibition.

Publications per year

2024–2024

Publications

Impact of EML4-ALK Variants and Co-Occurring TP53 Mutations on Duration of First-Line ALK Tyrosine Kinase Inhibitor Treatment and Overall Survival in ALK Fusion-Positive NSCLC: Real-World Outcomes From the GuardantINFORM database

Kaushal Parikh, Anastasios Dimou, Konstantinos Leventakos et al. · Journal of Thoracic Oncology · 2024 · 31 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

1–1 of 1